- Home
- NVFY vs OTLK Comparison
NVFY vs OTLK Comparison
Compare NVFY & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- OTLK
- Stock Information
- Founded
- NVFY 2003
- OTLK 2010
- Country
- NVFY United States
- OTLK United States
- Employees
- NVFY N/A
- OTLK N/A
- Industry
- NVFY Home Furnishings
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVFY Consumer Discretionary
- OTLK Health Care
- Exchange
- NVFY Nasdaq
- OTLK Nasdaq
- Market Cap
- NVFY 36.8M
- OTLK 42.8M
- IPO Year
- NVFY N/A
- OTLK 2016
- Fundamental
- Price
- NVFY $5.64
- OTLK $1.28
- Analyst Decision
- NVFY
- OTLK Buy
- Analyst Count
- NVFY 0
- OTLK 5
- Target Price
- NVFY N/A
- OTLK $5.25
- AVG Volume (30 Days)
- NVFY 1.2M
- OTLK 1.8M
- Earning Date
- NVFY 11-13-2025
- OTLK 08-14-2025
- Dividend Yield
- NVFY N/A
- OTLK N/A
- EPS Growth
- NVFY N/A
- OTLK N/A
- EPS
- NVFY N/A
- OTLK N/A
- Revenue
- NVFY $9,813,990.00
- OTLK $1,505,322.00
- Revenue This Year
- NVFY N/A
- OTLK N/A
- Revenue Next Year
- NVFY N/A
- OTLK $342.80
- P/E Ratio
- NVFY N/A
- OTLK N/A
- Revenue Growth
- NVFY N/A
- OTLK N/A
- 52 Week Low
- NVFY $0.39
- OTLK $0.79
- 52 Week High
- NVFY $6.08
- OTLK $6.98
- Technical
- Relative Strength Index (RSI)
- NVFY 66.20
- OTLK 49.12
- Support Level
- NVFY $5.39
- OTLK $1.28
- Resistance Level
- NVFY $5.77
- OTLK $1.48
- Average True Range (ATR)
- NVFY 0.26
- OTLK 0.11
- MACD
- NVFY -0.05
- OTLK 0.00
- Stochastic Oscillator
- NVFY 65.59
- OTLK 27.78
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.